Kliovance is a hormone replacement therapy (HRT) medication primarily prescribed to women undergoing menopause. It contains two active ingredients: estradiol, a form of estrogen, and norethisterone acetate, a type of progestogen. This combination helps alleviate symptoms associated with menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness, by compensating for the decrease in estrogen production in the body. Kliovance is also used to prevent osteoporosis in postmenopausal women, reducing the risk of fractures by maintaining bone density. It is typically available in tablet form and should be taken as directed by a healthcare professional to ensure its effectiveness and minimize potential side effects.